Selected research
Industry Growth & Trends
Global Tumor Models Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Tumor Models market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Tumor Models is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Tumor Models is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Tumor Models is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Tumor Models market include Labcorp, IITRI, InSphero, Biomodels, Reaction Biology, Oncodesign Services, Creative Biolabs, Abnova and Invivocue, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Tumor Models market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Tumor Models market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tumor Models market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tumor Models.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Tumor Models market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Tumor Models Market by Company
Labcorp
IITRI
InSphero
Biomodels
Reaction Biology
Oncodesign Services
Creative Biolabs
Abnova
Invivocue
Inotiv
Charles River
WuXi Biology
Tumor Models Segment by Type
Cell Line-derived Xenograft (CDX) Tumor Models
Patient-derived Xenograft (PDX) Tumor Models
Syngeneic Tumor Models
Others
Tumor Models Segment by Application
Clinical Trials
Academic Research
Others
Tumor Models Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Models market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tumor Models and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Models.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Tumor Models companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Cell Line-derived Xenograft (CDX) Tumor Models
- Patient-derived Xenograft (PDX) Tumor Models
- Syngeneic Tumor Models
- Others
Applications
- Clinical Trials
- Academic Research
- Others
Companies covered
- Labcorp
- IITRI
- InSphero
- Biomodels
- Reaction Biology
- Oncodesign Services
- Creative Biolabs
- Abnova
- Invivocue
- Inotiv
- Charles River
- WuXi Biology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Tumor Models Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Tumor Models Market Size by Region (2021-2032)
- 1.4.1 Global Tumor Models Market Size by Region (2021-2026)
- 1.4.2 Global Tumor Models Market Size by Region (2027-2032)
- 1.5 Key Regions Tumor Models Market Size (2021-2032)
- 1.5.1 North America Tumor Models Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Tumor Models Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Tumor Models Market Size Growth Rate (2021-2032)
- 1.5.4 South America Tumor Models Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Tumor Models Market Size Growth Rate (2021-2032)
2 Tumor Models Market by Type
- 2.1 Type Introduction
- 2.1.1 Cell Line-derived Xenograft (CDX) Tumor Models
- 2.1.2 Patient-derived Xenograft (PDX) Tumor Models
- 2.1.3 Syngeneic Tumor Models
- 2.1.4 Others
- 2.2 Global Tumor Models Market Size by Type
- 2.2.1 Global Tumor Models Market Size Overview by Type (2021-2032)
- 2.2.2 Global Tumor Models Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Tumor Models Market Size Forecasted by Type (2027-2032)
- 2.3 Global Tumor Models Market Size by Regions
- 2.3.1 North America Tumor Models Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Tumor Models Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Tumor Models Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Tumor Models Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Tumor Models Market Size Breakdown by Type (2021-2026)
3 Tumor Models Market by Application
- 3.1 Type Introduction
- 3.1.1 Clinical Trials
- 3.1.2 Academic Research
- 3.1.3 Others
- 3.2 Global Tumor Models Market Size by Application
- 3.2.1 Global Tumor Models Market Size Overview by Application (2021-2032)
- 3.2.2 Global Tumor Models Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Tumor Models Market Size Forecasted by Application (2027-2032)
- 3.3 Global Tumor Models Market Size by Regions
- 3.3.1 North America Tumor Models Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Tumor Models Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Tumor Models Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Tumor Models Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Tumor Models Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Tumor Models Industry Trends
- 4.2 Tumor Models Industry Drivers
- 4.3 Tumor Models Industry Opportunities and Challenges
- 4.4 Tumor Models Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Tumor Models Revenue (2021-2026)
- 5.2 Global Tumor Models Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Tumor Models Key Company Headquarters & Area Served
- 5.4 Global Tumor Models Company, Product Type & Application
- 5.5 Global Tumor Models Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Tumor Models Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Tumor Models Players Market Share by Revenue in 2025
- 5.6.3 2025 Tumor Models Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Labcorp
- 6.1.1 Labcorp Company Information
- 6.1.2 Labcorp Business Overview
- 6.1.3 Labcorp Tumor Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Labcorp Tumor Models Product Portfolio
- 6.1.5 Labcorp Recent Developments
- 6.2 IITRI
- 6.2.1 IITRI Company Information
- 6.2.2 IITRI Business Overview
- 6.2.3 IITRI Tumor Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 IITRI Tumor Models Product Portfolio
- 6.2.5 IITRI Recent Developments
- 6.3 InSphero
- 6.3.1 InSphero Company Information
- 6.3.2 InSphero Business Overview
- 6.3.3 InSphero Tumor Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 InSphero Tumor Models Product Portfolio
- 6.3.5 InSphero Recent Developments
- 6.4 Biomodels
- 6.4.1 Biomodels Company Information
- 6.4.2 Biomodels Business Overview
- 6.4.3 Biomodels Tumor Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Biomodels Tumor Models Product Portfolio
- 6.4.5 Biomodels Recent Developments
- 6.5 Reaction Biology
- 6.5.1 Reaction Biology Company Information
- 6.5.2 Reaction Biology Business Overview
- 6.5.3 Reaction Biology Tumor Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Reaction Biology Tumor Models Product Portfolio
- 6.5.5 Reaction Biology Recent Developments
- 6.6 Oncodesign Services
- 6.6.1 Oncodesign Services Company Information
- 6.6.2 Oncodesign Services Business Overview
- 6.6.3 Oncodesign Services Tumor Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Oncodesign Services Tumor Models Product Portfolio
- 6.6.5 Oncodesign Services Recent Developments
- 6.7 Creative Biolabs
- 6.7.1 Creative Biolabs Company Information
- 6.7.2 Creative Biolabs Business Overview
- 6.7.3 Creative Biolabs Tumor Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Creative Biolabs Tumor Models Product Portfolio
- 6.7.5 Creative Biolabs Recent Developments
- 6.8 Abnova
- 6.8.1 Abnova Company Information
- 6.8.2 Abnova Business Overview
- 6.8.3 Abnova Tumor Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Abnova Tumor Models Product Portfolio
- 6.8.5 Abnova Recent Developments
- 6.9 Invivocue
- 6.9.1 Invivocue Company Information
- 6.9.2 Invivocue Business Overview
- 6.9.3 Invivocue Tumor Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Invivocue Tumor Models Product Portfolio
- 6.9.5 Invivocue Recent Developments
- 6.10 Inotiv
- 6.10.1 Inotiv Company Information
- 6.10.2 Inotiv Business Overview
- 6.10.3 Inotiv Tumor Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Inotiv Tumor Models Product Portfolio
- 6.10.5 Inotiv Recent Developments
- 6.11 Charles River
- 6.11.1 Charles River Company Information
- 6.11.2 Charles River Business Overview
- 6.11.3 Charles River Tumor Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Charles River Tumor Models Product Portfolio
- 6.11.5 Charles River Recent Developments
- 6.12 WuXi Biology
- 6.12.1 WuXi Biology Company Information
- 6.12.2 WuXi Biology Business Overview
- 6.12.3 WuXi Biology Tumor Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 WuXi Biology Tumor Models Product Portfolio
- 6.12.5 WuXi Biology Recent Developments
7 North America
- 7.1 North America Tumor Models Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Tumor Models Market Size by Country (2021-2026)
- 7.3 North America Tumor Models Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Tumor Models Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Tumor Models Market Size by Country (2021-2026)
- 8.3 Europe Tumor Models Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Tumor Models Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Tumor Models Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Tumor Models Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Tumor Models Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Tumor Models Market Size by Country (2021-2026)
- 10.3 South America Tumor Models Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Tumor Models Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Tumor Models Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Tumor Models Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst